Bioleaders Corporation (142760) — Free Cash Flow Generation Index

Latest as of September 2024: -17.47x

Bioleaders Corporation (142760) has a Free Cash Flow Generation Index of -17.47x as of September 2024. Free cash flow of ₩-866.03 Million represents -17% of operating cash flow (₩49.56 Million). See Bioleaders Corporation working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

-17.47x
Free Cash Flow / Operating CF

Free Cash Flow

₩-866.03 Million
KRW

Operating Cash Flow

₩49.56 Million
KRW

Capital Expenditures

₩1.04 Billion
KRW

Bioleaders Corporation Free Cash Flow Generation Index (2023–2023)

Historical FCF Generation Index trend for Bioleaders Corporation across 1 annual periods. Explore cash flow to debt ratio of Bioleaders Corporation to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Bioleaders Corporation (2023–2023)

Year-by-year Free Cash Flow Generation Index for Bioleaders Corporation. For the full company profile including market capitalisation, see market value of Bioleaders Corporation.

Year FCG Index Free Cash Flow (KRW) Operating CF Capital Expenditures YoY Change
2023 0.94x ₩5.80 Billion ₩6.18 Billion ₩378.81 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).